Reduced transdermal absorption of N,N-diethyl-m-toluamide from a new topical insect repellent formulation

Pharmaceutical Development and Technology

Volumn 2, Issue 1, 1997, Pages 33-42

  Qiu, Hongchun ^a   Jun, H Won ^a   Dzimianski, Michael ^a   McCall, John ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

DEET; Reduced transdermal absorption; Relative repellency; Skin permeation; Topical insect repellent

Indexed keywords

INSECT REPELLENT;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PENETRATION; PRIORITY JOURNAL; SKIN PERMEABILITY; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031398652     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459709022607     Document Type: Article

References (34)

1. R. J. Feldmann and H. I. Maibach, Absorption of some organic compounds through the skin in man, J. Invest. Dermatol., 54, 399-404 (1970).
2. A. W. Smallwood, K. E. DeBord, and L. K. Lowry, N,N'-diethyl-m-toluamide (m-DET): Analysis of an insect repellent in human urine and serum by high-performance liquid chromatography, J. Anal. Toxicol., 16, 10-13 (1992).
3. W. G. Taylor, T. J. Danielson, R. W. Spooner, and L. R. Golsteyn, Pharmacokinetic assessment of the dermal absorption of N,N-diethyl-m-toluamide (DEET) in cattle, Drug Metabol. Dispos., 22, 106-112 (1994).
4. Pesticide Registration Standard - DEET, U.S. Environmental Protection Agency, Washington, DC, December 1980.
5. J. C. Veltri, T. G. Osimitz, D. C. Bradford, and B. C. Page, Retrospective analysis of calls to poison control centers resulting from exposure to the insect repellent N,N-diethyl-m-toluamide (DEET) from 1985-1989, Clin. Toxicol., 32, 1-16 (1994).
6. P. J. Robinsons and M. G. Cherniack, Review of the biodistribution and toxicology of the insect repellent N,N-diethyl-m-toluamide (DEET), J. Toxicol. Environ. Health, 18, 503-505 (1986).
7. J. Pronczuk and E. Fogel, Toxicity of an insect repellent: N,N-diethyl-m-toluamide, Vet. Hum. Toxicol., 25, 422-423 (1983).
8. H. M. C. Heick, R. T. Shipman, B. Chir, M. G. Norman, and W. James, Reye-like syndrome associated with use of insect repellent in a presumed heterozygote for ornithine carbamoyl transferase deficiency, J. Pediatr., 97, 471-473 (1983).
9. D. L. Edwards and C. E. Johnson, Insect-repellent-induced toxic encephalopathy in a child, Clin. Pharm., 6, 496-498 (1987).
10. E. H. Roland, J. E. Jan, and J. M. Rigg, Toxic encephalopathy in a child after brief exposure to insect repellents. Can. Med. Assoc. J., 132, 155-156 (1985).
11. J. Gryboski, D. Weinstein, and N. K. Ordway, Toxic encephalopathy apparently related to the use of insect repellent, N. Engl. J. Med., 264, 289-291 (1961).
12. J. W. Snyder, R. O. Poe, J. F. Stubbins, and L. K. Garrettson, Acute manic psychosis following the dermal application of N,N-diethyl-m-toluamide (DEET) in an adult, Clin. Toxicol., 24, 429-439 (1986).
13. J. W. Lipscomb, J. E. Kramer, and J. B. Leikin, Seizure following brief exposure to the insect repellent N,N-diethyl-m-toluamide, Ann. Emerg. Med., 21, 315-317 (1992).
14. J. R. Clem, D. F. Havemann, and M. A. Raebel, Insect repellent (N,N-diethyl-m-toluamide) cardiovascular toxicity in an adult, Ann. Pharmacother., 27, 289-293 (1993).
15. H. Reuveni and P. Yagupsky, Diethyltoluamide-containing insect repellent: Adverse effects in worldwide use, Arch. Dermatol., 118, 582-583 (1982).
16. H. I. Maibach and H. L. Johnson, Contact urticaria syndrome: Contact urticaria to diethyltoluamide, Arch. Dermatol., 111, 726-730 (1975).
17. R.L. Bronaugh, Diffusion cell design, in Topical Drug Bioavailability, Bioequivalence and Penetration (V. P. Shah and H. I. Maibach, eds.), Plenum Press, New York, 1993, pp. 117-125.
18. H. L. Snodgrass, D. C. Nelson, and M. H. Weeks, Dermal penetration and potential for placental transfer of the insect repellent N,N-diethyl-m-toluamide, Am. Ind. Hyg. Assoc. J., 43, 747-753 (1982).
19. H. Qiu and H. W. Jun, Solid-phase extraction and liquid chromatographic quantitation of insect repellent N,N-diethyl-m-toluamide in plasma, J. Pharm. Biomed. Anal., 15, 241-250 (1996).
20. Technical Bulletin No. 1285, Agriculture Research Service, USDA, 1963.
21. S. Budavari (ed.), The Merck Index, 11th ed., Merck & Co., Rahway, NJ, 1989.
22. T. Higuchi, Rate of release of medications from ointment bases containing drugs in suspension, J. Pharm. Sci., 50, 874-875 (1961).
23. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982.
24. R. J. Gupta and L. C. Rutledge, Laboratory evaluation of controlled-release repellent formulations on human volunteers under three climatic regimens, J. Am. Mosq. Control Assoc., 5, 52-55 (1989).
25. Forum: Bug spray worse than the bite? Environ. Health Perspect., 102, 910 (1994).
26. C. Liu, H. Ho, M. Hsieh, T. D. Sokoloski, and M. Sheu, Studies on the in-vitro penetration of indomethacin from gel systems in hairless mice, J. Pharm. Pharmacol., 47, 365-372 (1995).
27. N. V. Sheth, D. J. Freeman, W. I. Higuchi, and S. L. Spruance, The influence of Azone, propylene glycol and polyethylene glycol on in vitro skin penetration of trifluorothymidine, Int. J. Pharm., 28, 201-209 (1986).
28. D. J. Freeman, N. V. Sheth, and S. L. Spruance, Failure of topical acyclovir in ointment to penetrate human skin, Antimicrob. Agents Chemother., 29, 730-732 (1986).
29. J. Hadgraft, Percutaneous absorption: Possibilities and problems, Int. J. Pharm., 16, 255-270 (1983).
30. S. S. Davis, J. Hadgraft, and K. I. Al-Khamis, Percutaneous absorption of methyl salicylate from polyethylene glycol vehicles, J. Pharm. Pharmacol., 33, 97p (1981).
31. B. Kammerau, A. Zesch, and H. Schaefer, Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment - in vivo investigations with four different types of pharmaceutical vehicle, J. Invest. Dermatol., 64, 145-149 (1975).
32. K. I. Al-Khamis, S. S. Davis, and J Hadgraft, Microviscosity and drug release from topical gel formulations, Pharm. Res., 3, 214-217 (1984).
33. Introducing the new, universal Pemulen® polymeric emulsifiers, TDS-182, BFGoodrich Specialty Chemicals, Cleveland, OH, 1994.
34. K. D. Bremecker, B. Koch, W. Krause, and L. Neuenroth, Application triggered drug release from an O/W-emulsion, Pharm. Ind., 54, 182-185 (1992).